http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9918790-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c47cfaf674c99c58764f9708d2e0f416
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00363
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1492
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-14
filingDate 2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b2cea826f73117745cc9d4cc2578aa
publicationDate 2018-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9918790-B2
titleOfInvention Ablation of myocardial tissues with nanosecond pulsed electric fields
abstract An apparatus and methods for performing ablation of myocardial tissues are disclosed. The apparatus includes a plurality of ablation electrode configurations to which nanosecond pulsed electric fields are applied. The methods relate to therapies to treat cardiac arrhythmias, such as, atrial fibrillation and scar-related ventricular tachycardia, amongst others. The affected myocardial tissues are ablated creating a plurality of lesions enabled by the nanosecond pulsed electric fields applied to either penetrating electrodes, endo-endo electrodes, or endo-epi electrodes. Different electrophysiological tests are performed to assess the application of nanosecond pulsed electric field ablation to specific desired tissue location within the heart. Test results show the potential to overcome limitations of current ablation therapies, thereby providing patients and doctors a superior treatment for cardiac arrhythmias.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786300-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11696800-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874451-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11051882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723712-B2
priorityDate 2014-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010023004-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7435247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6827714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005261672-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016184003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8100899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013030430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012059255-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013019385-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453947315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3476986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425985677

Total number of triples: 38.